Read the latest positive news, breakthroughs, and inspiring stories about hiv research, curated daily by BrightWire.
A groundbreaking clinical trial shows that special antibodies may train the immune system to control HIV for years without daily medication. One participant has now gone more than three years without needing antiretroviral therapy.
%2Ffile%2Fattachments%2F2996%2FGroundUp-NIH-funding_260278.jpeg)
After nearly 18 months of halted funding that threatened decades of HIV and TB research, the US National Institutes of Health has reversed its ban on South Africa. The decision restores hope for global health progress and hundreds of research jobs.
Scientists are getting closer to an HIV cure, but advocates want to make sure long-term survivors don't lose vital benefits when breakthrough treatments arrive. Researchers and survivor groups are calling for policy protections now, before medical progress leaves vulnerable patients behind.
Two Nigerian pharmacists are calling for their country to stop being just a recipient of medical breakthroughs and start creating them. They want Nigeria to invest in HIV drug discovery so local scientists can help shape the future of treatment.
Scientists discovered that common flu antivirals like Tamiflu might help reverse the inflammation causing cognitive problems in people living with HIV. The breakthrough could improve quality of life for millions as the HIV population ages.
A rare group of people can naturally suppress HIV without medication, and their immune systems may hold the key to curing 40 million people worldwide. Researchers studying these "elite controllers" believe they're closer than ever to understanding how the human body can beat HIV on its own.
A rare group of people can suppress HIV without medication, and researchers studying them just discovered something remarkable: some may be completely cured. These "elite controllers" could hold the key to helping 40 million people worldwide beat the virus.
Three people have kept HIV suppressed for up to 7.5 years without daily medication, and scientists finally know why. Their immune systems learned to attack the virus from two directions at once.
%2Ffile%2Fattachments%2Forphans%2FProfessorWillemHanekom_276321.jpeg)
Professor Willem Hanekom is co-leading a 20,000-person global trial for the world's most promising TB vaccine while directing Africa's largest health research institute. Living openly with HIV for 19 years, he's dedicated his career to bringing life-saving treatments to underresourced communities.
When US funding cuts threatened to collapse decades of life-saving health research in South Africa, the country fought back with a $32 million rescue package. Now 59 critical HIV and tuberculosis research projects are moving forward.
A groundbreaking UCSF trial used three therapies to help immune systems hunt hidden HIV, showing unprecedented results. Ten volunteers endured painful treatments to advance science toward a cure for the disease that's infected 1.3 million people worldwide in 2024.
Researchers created a breakthrough nanodisc system that shows viruses in their true form, revealing hidden weak points that could lead to more effective vaccines. The technology speeds up vaccine development from months to just one week.